CONEX PEDIATRIC- dexbrompheniramine maleate, pseudoephedrine hcl liquid

Conex Pediatric by

Drug Labeling and Warnings

Conex Pediatric by is a Otc medication manufactured, distributed, or labeled by Llorens Pharmaceutical International Division. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Active Ingredients (in each 5 mL tsp.)

Dexbrompheniramine Maleate, USP .......... 1 mg .................... Antihistamine

Pseudoephedrine HCL, USP ............ 30 mg ...................... Nasal Decongestant

PURPOSE

Antihistamine

Nasal Decongestant

INDICATIONS & USAGE

Uses

• Temporarily relieves nasal congestion due to the common cold, hay fever or other upper repiratory allergies
• helps decongest sinus opening and sinus passages
• reduces swelling of nasal passages, shrinks swollen membranes, and temporarily restores freer breathing through the nose
• temporarily alleviates the following symptoms due to hay fever (allergic rhinitis)
• runny nose
• sneezing
• itching of the nose or throat
• ithy and watery eyes

WARNINGS

Warnings:

• Do not use ifyou are taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if you are taking a prescription drug that contains an MAOI, ask your doctor or pharmacist before taking this product.

DO NOT USE

Ask a doctor before use if you aretaking sedatives or tranquilizers.

Ask a doctor before use if you have

• heart disease
• high blood pressure
• thyroid disese
• diabetes
• difficulty in urination due to the enlargement of the prostate gland.

When using this product

• do not exceed the recommended dosage
• excitability may occur, especially in children
• drowsiness may occur
• avoid alcoholic beverages
• alcohol, sedatives and tranquilizers may increase drowsiness
• use caution when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

• nervousness, dizziness or sleeplessness occur
• symptoms do not improve within 7 days or occur with a fever.

KEEP OUT OF REACH OF CHILDREN

Keep out of the reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.

PREGNANCY OR BREAST FEEDING

If pregnant or breast-feeding,ask a Health Professional before use.

DOSAGE & ADMINISTRATION

Directions:Do not exceed more than 4 doses in any 24-hour period or as directed by a doctor.

• Age: Dose
• Adults and children 12 years of age and over: take two teaspoonfuls (10 mL) every 4 to 6 hours
• Children under 12 years of age: take 1 teaspoonful (5 mL) every 4 to 6 hours
• Children under 6 years of age: ask a doctor

INACTIVE INGREDIENT

Inactive Ingredients: citric acid, flavor, glycerine, menthol, methylparaben, propylene glycol, propylparaben, purified water, sodium citrate and sucralose

QUESTIONS

Questions or Comments? 1-866-595-5598

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CONEX PEDIATRIC 
dexbrompheniramine maleate, pseudoephedrine hcl liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 54859-803
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DEXBROMPHENIRAMINE MALEATE (UNII: BPA9UT29BS) (DEXBROMPHENIRAMINE - UNII:75T64B71RP)	DEXBROMPHENIRAMINE MALEATE	1 mg  in 5 mL
PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F)	PSEUDOEPHEDRINE HYDROCHLORIDE	30 mg  in 5 mL

Inactive Ingredients
Ingredient Name	Strength
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
GLYCERIN (UNII: PDC6A3C0OX)
MENTHOL (UNII: L7T10EIP3A)
METHYLPARABEN (UNII: A2I8C7HI9T)
WATER (UNII: 059QF0KO0R)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
SUCRALOSE (UNII: 96K6UQ3ZD4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 54859-803-16	473 mL in 1 BOTTLE; Type 0: Not a Combination Product	12/01/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M012	12/01/2024

Labeler - Llorens Pharmaceutical International Division (037342305)